CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors
Jiawan Wang(Johns Hopkins University), Christine A. Pratilas(Johns Hopkins University)
Cited by 26
Related Papers
BRAF mutation predicts sensitivity to MEK inhibition
|Nature|2005|1.3k
The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
|Proceedings of the National Academy of Sciences|2010|447
Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence
|Cancer Research|2014|310
Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG)
|Neuro-Oncology|2022|136
Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor
|Cancer Immunology Research|2013|120